TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/1/25 18:41 | 6/30/25 | KYMR | Kymera Therapeutics, Inc. | DE | Financ | InvAdv | Investment Advice | Bvf Partners L P/Il | CA | DH | See Rema | P.d | 13,955 | 44.00 | 0 | 317 | 875 | 353 | D | ||||||||||||||
5/13/24 17:04 | 5/9/24 | ELDN | Eledon Pharmaceuticals, Inc. | DE | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | T | P.d | 0 | 0.00 | 0 | 1,928 | 220 | D | ||||||||||||||||
11/17/23 16:54 | 11/15/23 | RPTX | Repare Therapeutics Inc. | DE | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | T | P.m | 6,250 | 5.09 | 0 | 1,227 | 549 | D | ||||||||||||||||
11/6/23 18:07 | 11/2/23 | KYMR | Kymera Therapeutics, Inc. | DE | Financ | InvAdv | Investment Advice | Bvf Partners L P/Il | CA | DH | See Rema | P.dm | 5,301 | 12.80 | 0 | 414 | 295 | D | |||||||||||||||
11/3/23 17:37 | 11/2/23 | RPTX | Repare Therapeutics Inc. | DE | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | T | P | 2,821 | 3.60 | 0 | 784 | 485 | D | ||||||||||||||||
9/14/23 16:25 | 9/12/23 | OLMA | Olema Pharmaceuticals, Inc. | DE | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | DT | P.d | 14,818 | 9.84 | 0 | 1,506 | 624 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |